As the US-China technology rivalry deepens, the race for next-generation AI infrastructure is turning away from conventional chips. A Shanghai…
As the US-China technology rivalry deepens, the race for next-generation AI infrastructure is turning away from conventional chips. A Shanghai startup’s impending Hong Kong listing…
Three decades of parallel biotech ambition have left Hong Kong trailing Singapore by a significant distance. Yet the emergence of the Greater Bay Area offers…
While the global race for quantum computing leadership intensifies, China is signalling a strategic pivot: embedding advanced technologies like quantum communication and artificial intelligence into…
As geopolitical friction deepens and demand for next-generation computing surges, China’s push into alternative AI hardware architectures is no longer a laboratory curiosity. The imminent…
For global biotech investors and pharmaceutical strategists, the lesson is clear: China’s life sciences future is increasingly a story of regional ecosystems, not just national…
For global investors and technology executives, Beijing’s long-term blueprint signals that China is not merely catching up in frontier technologies but is building the industrial…
As conventional chip architectures face diminishing returns, photonic computing offers a path forward for AI workloads — and Chinese companies are moving swiftly to commercialise…
As US-China competition intensifies, China’s bet on silicon photonic computing for AI infrastructure is moving from the lab to the public markets — and global…
For global biotech professionals and investors, the contrast between Hong Kong and Singapore offers a cautionary tale—and a reminder that institutional infrastructure, talent pipelines, and…
For global investors, researchers, and strategic planners, Beijing’s new five-year plan signals a definitive state-backed shift to turn quantum communication and AI into core drivers…
No products in the cart.
